Eu­rope to buy 110k dos­es of Bavar­i­an Nordic's mon­key­pox vac­cine — as EU-li­censed vac­cine not eas­i­ly ac­ces­si­ble

Known mon­key­pox cas­es rose above the 4,000 mark this week as of­fi­cials have sought an­oth­er name for the dis­ease, and Eu­ro­peans moved for­ward on stock­ing up a work­ing vac­cine.

The Eu­ro­pean Med­i­cines Agency an­nounced Mon­day that it had agreed to buy 110,000 dos­es of Jyn­neos, the US-li­censed ver­sion of Bavar­i­an Nordic’s Im­vanex. Im­vanex is au­tho­rized in the EU for the pre­ven­tion of small­pox in adults, but on­ly “un­der ex­cep­tion­al cir­cum­stances due to the im­pos­si­bil­i­ty to gen­er­ate ef­fi­ca­cy da­ta as small­pox virus is no longer cir­cu­lat­ing.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER